These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 8382381

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Results of the North American trial of piperacillin/tazobactam compared with clindamycin and gentamicin in the treatment of severe intra-abdominal infections. Investigators of the Piperacillin/Tazobactam Intra-abdominal Infection Study Group.
    Eur J Surg Suppl; 1994; (573):61-6. PubMed ID: 7524798
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Piperacillin-tazobactam versus imipenem-cilastatin for treatment of intra-abdominal infections.
    Brismar B, Malmborg AS, Tunevall G, Wretlind B, Bergman L, Mentzing LO, Nyström PO, Kihlström E, Bäckstrand B, Skau T.
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2766-73. PubMed ID: 1336347
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study.
    Norrby SR, Vandercam B, Louie T, Runde V, Norberg B, Anniko M, Andrien F, Baudrihaye M, Bow E, Burman LA.
    Scand J Infect Dis Suppl; 1987 Dec; 52():65-78. PubMed ID: 3331044
    [Abstract] [Full Text] [Related]

  • 8. Piperacillin/tazobactam compared with cefuroxime/ metronidazole in the treatment of intra-abdominal infections.
    Ohlin B, Cederberg A, Forssell H, Solhaug JH, Tveit E.
    Eur J Surg; 1999 Sep; 165(9):875-84. PubMed ID: 10533765
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cost efficacy of tazobactam/piperacillin versus imipenem/cilastatin in the treatment of intra-abdominal infection.
    Dietrich ES, Schubert B, Ebner W, Daschner F.
    Pharmacoeconomics; 2001 Jan; 19(1):79-94. PubMed ID: 11252548
    [Abstract] [Full Text] [Related]

  • 11. Piperacillin and tazobactam versus clindamycin and gentamicin in the treatment of hospitalized women with pelvic infection. The Piperacillin/tazobactam Study Group.
    Sweet RL, Roy S, Faro S, O'Brien WF, Sanfilippo JS, Seidlin M.
    Obstet Gynecol; 1994 Feb; 83(2):280-6. PubMed ID: 8290195
    [Abstract] [Full Text] [Related]

  • 12. Imipenem/cilastatin versus piperacillin/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients: results of the COSTINE study.
    Sanz MA, Bermúdez A, Rovira M, Besalduch J, Pascual MJ, Nocea G, Sanz-Rodríguez C, COSTINE Study Group.
    Curr Med Res Opin; 2005 May; 21(5):645-55. PubMed ID: 15969864
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of piperacillin/tazobactam in skin and soft tissue infections.
    File TM, Tan JS.
    Eur J Surg Suppl; 1994 May; (573):51-5. PubMed ID: 7524796
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of piperacillin/tazobactam in intra-abdominal infections.
    Vestweber KH, Grundel E.
    Eur J Surg Suppl; 1994 May; (573):57-60. PubMed ID: 7524797
    [Abstract] [Full Text] [Related]

  • 18. The treatment of severe intra-abdominal infections: the role of piperacillin/tazobactam.
    Nord CE.
    Intensive Care Med; 1994 Jul; 20 Suppl 3():S35-8. PubMed ID: 7962987
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.